Evidence map›Paper›PMID 40486519›Full record

ArticleFrontiers in immunology2025

C1q reprograms innate immune memory.

Inge Jonkman, Maaike M E Jacobs, Yutaka Negishi, Julia I P van Heck, Vasiliki Matzaraki, Joost H A Martens, Marijke Baltissen, Michiel Vermeulen, Zahi A Fayad, Abraham J P Teunissen and 7 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Inge JonkmanDepartment of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Maaike M E JacobsDepartment of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Yutaka NegishiDepartment of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, Netherlands.
Julia I P van HeckDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Vasiliki MatzarakiDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Joost H A MartensDepartment of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, Netherlands.
Marijke BaltissenDepartment of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, Netherlands.
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, Netherlands.
Zahi A FayadBiomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Abraham J P TeunissenBiomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Willem J M MulderDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Luuk B HilbrandsDepartment of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Leo A B JoostenDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Mihai G NeteaDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Musa M MhlangaDepartment of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, Netherlands.
Nils RotherDepartment of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.
Raphaël DuivenvoordenDepartment of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.

Funding

Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primatesP01AI168258 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Abraham Teunissen · 2023 to 2026
$14.7M
NIAID NIH HHS P01 AI168258
6 · The paper itself

Abstract

Innate immune memory, also called trained immunity, is a metabolic and epigenetically regulated process that enables innate immune cells to recalibrate their inflammatory reactivity in response to pathogenic or endogenous stimuli. In addition to its function in host defense, trained immunity contributes to diverse immune-mediated diseases. We discovered that complement component 1q (C1q) is an effective modulator of innate immune memory, potently suppressing the responsiveness of myeloid cells. We found that C1q leads to profound reprogramming of myeloid cell metabolism, particularly glycolysis, and exerts control over the transcriptional regulation of important metabolic and inflammatory genes. We corroborate our findings by identifying single-nucleotide polymorphisms close to the C1q gene that are linked to induction of trained immunity by Bacillus Calmette-Guérin (BCG) or beta-glucan in healthy peripheral blood mononuclear cells. Our results reveal an immunomodulatory role for C1q and provide evidence of a molecular interaction between the complement system and innate immune memory. These findings expand our understanding of innate immune memory.

Indexed as

Complement C1qImmunity, InnateImmunologic MemoryMyeloid Cellsbeta-GlucansGlycolysisHumansLeukocytes, MononuclearPolymorphism, Single NucleotideTrained Immunitybeta-GlucansComplement C1qC1qcomplementimmunometabolisminnate immune memorytolerancetrained immunity

Identifiers

PMID40486519
PMCPMC12141851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.